French PAE member Association Francophone pour Vaincre les Douleurs (AFVD) is part of the Temporary Special Scientific Committee (CSST) set up by the National Agency for the Safety of Medicines and Health Products (ANSM) to evaluate the relevance and feasibility of the provision of therapeutic cannabis. in France.
After three meetings devoted to stakeholder hearings, the committee considered that it was relevant to authorize the use of cannabis for therapeutic purposes for patients in certain clinical situations: patients for whom pain is refractory to accessible therapies (medicated or not) , in case of insufficient relief or a poor tolerance of the accessible treatment (medicated or not) .
This use can be considered in addition to or as a replacement for certain therapies. The smoking method has been excluded. The work will continue in 2019, and will focus on how to administer and monitor patients.
The retransmission of the auditions is available (in French) on the Youtube channel of National Agency for the Safety of Medicines and Health Products (ANSM) .